Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Conditioning regimen (myeloablative, reduced-intensity), Allogeneic stem cell transplant (allo-SCT), Allogeneic stem cell transplantation and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: myeloid and histiocytic neoplasms, Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine and the tag subtype-page.
Shares STAT5 (STAT5A, STAT5B), Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine and the tag subtype-page.
Shares Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine, Venetoclax and the tag subtype-page.
Shares Cytarabine + anthracycline ('7+3'), Cytarabine, Allogeneic stem cell transplantation, Azacitidine and the tag subtype-page.
Shares Cytarabine + anthracycline ('7+3'), Allogeneic stem cell transplantation, Azacitidine, Venetoclax and the tag subtype-page.
Shares Conditioning regimen (myeloablative, reduced-intensity), Allogeneic stem cell transplant (allo-SCT), Allogeneic stem cell transplantation, Small-molecule kinase inhibitors and the tag subtype-page.
Shares Allogeneic stem cell transplantation, Venetoclax, Cyclophosphamide and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.